# Chongqing Kangle Pharmaceutical Co., Ltd – FDA Inspection, Jul 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/chongqing-kangle-pharmaceutical-co-ltd/d6272298-6c9d-42d7-b3ad-95df1968b5f5
Source feed: FDA_Inspections

> FDA inspection 1064345 of Chongqing Kangle Pharmaceutical Co., Ltd, July 26, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1064345
- Company Name: Chongqing Kangle Pharmaceutical Co., Ltd
- Inspection Date: 2018-07-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1286254 - 2025-09-05](https://www.keypedia.com/records/fda_inspections/chongqing-kangle-pharmaceutical-co-ltd/0ae9e965-0baa-4ae0-ae7f-b42f8e6e62b6)
- FDA Inspection 912714 - 2015-01-30
- FDA Inspection 783920 - 2012-04-26

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dennis-cantellops-paite/3336bbb8-8520-4a8a-9085-76e7a55ca773)

Company: https://www.keypedia.com/companies/chongqing-kangle-pharmaceutical-co-ltd/10ee20e7-7e03-4bf3-835f-53e9c3c8ebfc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
